Matches in Nanopublications for { ?s ?p "[Reducing the number of weekly treatments per cycle from four to three and adding prophylactic dexamethasone, which abrogated interleukin-6 release and CRS (P < or = .01), resulted in improved tolerability and treatment delivery.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- NP496953.RAS2msL6Qzpj7F6bZH-zFT7CLJW7enX8Dfx3i8JB2DASs130_assertion description "[Reducing the number of weekly treatments per cycle from four to three and adding prophylactic dexamethasone, which abrogated interleukin-6 release and CRS (P < or = .01), resulted in improved tolerability and treatment delivery.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP496953.RAS2msL6Qzpj7F6bZH-zFT7CLJW7enX8Dfx3i8JB2DASs130_provenance.
- assertion description "[Reducing the number of weekly treatments per cycle from four to three and adding prophylactic dexamethasone, which abrogated interleukin-6 release and CRS (P < or = .01), resulted in improved tolerability and treatment delivery.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP769201.RAhC116XVcdWM7tqcAdmQyl_J2nr-R9Qvxh6gZUfLfgp8130_assertion description "[Reducing the number of weekly treatments per cycle from four to three and adding prophylactic dexamethasone, which abrogated interleukin-6 release and CRS (P < or = .01), resulted in improved tolerability and treatment delivery.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP769201.RAhC116XVcdWM7tqcAdmQyl_J2nr-R9Qvxh6gZUfLfgp8130_provenance.